Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

1.

In their own words: treating very young BRCA1/2 mutation-positive women with care and caution.

Hoskins LM, Werner-Lin A, Greene MH.

PLoS One. 2014 Feb 28;9(2):e87696. doi: 10.1371/journal.pone.0087696. eCollection 2014.

PMID:
24586286
[PubMed - in process]
Free PMC Article
2.

Chemoprevention of Breast Cancer: The Paradox of Evidence versus Advocacy Inaction.

Layeequr Rahman R, Pruthi S.

Cancers (Basel). 2012 Oct 29;4(4):1146-60. doi: 10.3390/cancers4041146.

PMID:
24213502
[PubMed]
Free PMC Article
3.

Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

Pfeiffer RM, Park Y, Kreimer AR, Lacey JV Jr, Pee D, Greenlee RT, Buys SS, Hollenbeck A, Rosner B, Gail MH, Hartge P.

PLoS Med. 2013;10(7):e1001492. doi: 10.1371/journal.pmed.1001492. Epub 2013 Jul 30.

PMID:
23935463
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study.

Pastor-Barriuso R, Ascunce N, Ederra M, Erdozáin N, Murillo A, Alés-Martínez JE, Pollán M.

Breast Cancer Res Treat. 2013 Feb;138(1):249-59. doi: 10.1007/s10549-013-2428-y. Epub 2013 Feb 3.

PMID:
23378108
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Estimating improvement in prediction with matched case-control designs.

Bansal A, Pepe MS.

Lifetime Data Anal. 2013 Apr;19(2):170-201. doi: 10.1007/s10985-012-9237-1. Epub 2013 Jan 29.

PMID:
23358916
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities.

McCaskill-Stevens W, Wilson JW, Cook ED, Edwards CL, Gibson RV, McElwain DL, Figueroa-Moseley CD, Paskett ED, Roberson NL, Wickerham DL, Wolmark N.

Clin Trials. 2013 Apr;10(2):280-91. doi: 10.1177/1740774512470315. Epub 2013 Jan 18.

PMID:
23335675
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A framework for organizing and selecting quantitative approaches for benefit-harm assessment.

Puhan MA, Singh S, Weiss CO, Varadhan R, Boyd CM.

BMC Med Res Methodol. 2012 Nov 19;12:173. doi: 10.1186/1471-2288-12-173. Review.

PMID:
23163976
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Lifetime risk for cancer death by sex and smoking status: the lifetime risk pooling project.

Gawron A, Hou L, Ning H, Berry JD, Lloyd-Jones DM.

Cancer Causes Control. 2012 Oct;23(10):1729-37. doi: 10.1007/s10552-012-9959-0. Epub 2012 Jul 24.

PMID:
22825072
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Using multiple risk models with preventive interventions.

Gail MH.

Stat Med. 2012 Oct 15;31(23):2687-96. doi: 10.1002/sim.5443. Epub 2012 Jun 26.

PMID:
22733645
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010.

Waters EA, McNeel TS, Stevens WM, Freedman AN.

Breast Cancer Res Treat. 2012 Jul;134(2):875-80. doi: 10.1007/s10549-012-2089-2. Epub 2012 May 24.

PMID:
22622807
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Exemestane for breast cancer prevention: a critical shift?

Decensi A, Dunn BK, Puntoni M, Gennari A, Ford LG.

Cancer Discov. 2012 Jan;2(1):25-40. doi: 10.1158/2159-8290.CD-11-0248. Review.

PMID:
22585166
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Role of disease risk scores in comparative effectiveness research with emerging therapies.

Glynn RJ, Gagne JJ, Schneeweiss S.

Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2:138-47. doi: 10.1002/pds.3231.

PMID:
22552989
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study.

Gu R, Jia W, Zeng Y, Rao N, Hu Y, Li S, Wu J, Jin L, Chen L, Long M, Chen K, Chen L, Xiao Q, Wu M, Song E, Su F.

BMC Cancer. 2012 May 1;12:161. doi: 10.1186/1471-2407-12-161.

PMID:
22548922
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Estimating the risks and benefits of tamoxifen for prophylactic breast cancer chemoprevention in Korea.

Kim DU, Min JW, Kim YM, Chang MC.

J Breast Cancer. 2012 Mar;15(1):51-6. doi: 10.4048/jbc.2012.15.1.51. Epub 2012 Mar 28.

PMID:
22493628
[PubMed]
Free PMC Article
15.

Premenopausal serum androgens and breast cancer risk: a nested case-control study.

Zeleniuch-Jacquotte A, Afanasyeva Y, Kaaks R, Rinaldi S, Scarmo S, Liu M, Arslan AA, Toniolo P, Shore RE, Koenig KL.

Breast Cancer Res. 2012 Feb 16;14(1):R32.

PMID:
22339988
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial.

Land SR, Cronin WM, Wickerham DL, Costantino JP, Christian NJ, Klein WM, Ganz PA.

Cancer Prev Res (Phila). 2011 Sep;4(9):1393-400. doi: 10.1158/1940-6207.CAPR-11-0172. Epub 2011 Aug 23.

PMID:
21862698
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effects of 17β-estradiol on proliferation, cell viability and intracellular redox status in native human lens epithelial cells.

Celojevic D, Petersen A, Karlsson JO, Behndig A, Zetterberg M.

Mol Vis. 2011;17:1987-96. Epub 2011 Jul 20.

PMID:
21850173
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Genetic variants in the MRPS30 region and postmenopausal breast cancer risk.

Huang Y, Ballinger DG, Dai JY, Peters U, Hinds DA, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, McTiernan A, Rohan T, Prentice RL.

Genome Med. 2011 Jun 24;3(6):42. doi: 10.1186/gm258.

PMID:
21702935
[PubMed]
Free PMC Article
19.

Fighting breast cancer: a call for a new paradigm.

Binstock M.

Perm J. 2005 Winter;9(1):73-6. No abstract available.

PMID:
21687489
[PubMed]
Free PMC Article
20.

Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.

Freedman AN, Yu B, Gail MH, Costantino JP, Graubard BI, Vogel VG, Anderson GL, McCaskill-Stevens W.

J Clin Oncol. 2011 Jun 10;29(17):2327-33. doi: 10.1200/JCO.2010.33.0258. Epub 2011 May 2. Erratum in: J Clin Oncol. 2013 Nov 10;31(32):4167.

PMID:
21537036
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk